Featured Articles

  MRI   Translational Research for Interventional Magnetic Resonance Imaging and Magnetic Resonance Visualisation of Vascular Implants
Andreas Melzer Director, Institute for Medical Science and Technology, Universities of Dundee and St Andrews
The new Dundee Clinical Research Centre (CRC) is a joint activity of the College of Medicine and NHS Tayside Ninewells Hospital and Medical School – one of the largest teaching hospitals in Europe.
 
         
  signal  

Safety Aspects in Carotid Artery Stenting - Is Flow Reversal the Solution?
Johan Formgren Head of Peripheral Vascular Interventions, Department of Medical Imaging, Södersjukhuset AB, Stockholm
Since the publication of the Endarterectomy versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) and Stent-supported Percutaneous Angioplasty of the Carotid Artery versus Endarterectomy (SPACE) studies, doubts have been raised regarding the safety of CAS as an alternative carotid intervention to CEA.

 
         
  Skylor stent
  LEONARDO - Clinical Evaluation of a Last Generation Coronary Stent in a Real World Typical Non-DES Population - A Prospective, Single-centre Registry
Jacques J Koolen and Maria Rosaria De Vita, Catharina Hospital, The Netherlands and Policlinico Gemelli Universita Cattolica Sacro Cuore, Italy
While rates of restenosis and MACEs have both been demonstrated to be significantly reduced with the use of drugeluting stents (DES) compared with BMS in a broad variety of trials,1–6 the same trials could not demonstrate any difference in mortality or AMI rates.
 


Percutaneous Coronary Intervention of Bifurcation Lesions - One Stent, Two Stents or a Dedicated Device
Cardiology
The Society for Cardiac Angiography and Interventions American Heart Association  Heart Online    Association of British Medical Journals   TCTMD
Cardiology » Articles » Percutaneous Coronary Intervention of Bifurcation Lesions - One Stent, Two Stents or a Dedicated Device
Wednesday, 23 July, 2008



Percutaneous Coronary Intervention of Bifurcation Lesions - One Stent, Two Stents or a Dedicated Device

Dr Thierry Lefevre Institut Cardiovasculaire Paris Sud, Massy , Dr Yves Louvard Institut Cardiovasculaire Paris Sud, Massy , Dr Marie-claude Morice Institut Cardiovasculaire Paris Sud, Massy

  Previous     1    2    3   4    Next  

The question as to whether one or two DES should be used cannot be answered on the basis of this study. The study showed a low rate (less than 6%) of main branch restenosis with the Cypher stent (regardless of the strategy) and an acceptable rate of side branch restenosis (22% in the two stents group compared with 14% in the balloon + stent group, p=not significant). To date, the reason for the excess of restenosis in the side branch has not been elucidated, though possible explanations may include geographical miss, lack of stent apposition at the carina and role of the technical approach.

In a more recent retrospective study, Ge et al., compared two treatment types with sirolimuseluting stents in 174 consecutive patients with bifurcation lesions (stenting only one branch in 57 or stenting both branches in 117). They found the same trend with DES (see Figure 5) as observed with BMS (see Figure 2) in favour of using one stent (incidence of target vessel revascularisation 5.4% compared with 11.1%, p=0.51 and cumulative MACE (18.9% compared with 23.3%, p=0.76) at nine months.

Figure 5: One or Two Drug-eluting Stents in Bifurcation Lesions

 

With the advent of DES, new techniques such as Crush or simultaneous kissing stent have been proposed in order to simplify the technical approach and reduce the risk of side branch restenosis. Recent data presented during the American College of Cardiology (ACC) scientific sessions did not demonstrate any benefit associated with these techniques. An excess of restenosis was even evidenced in the absence of final kissing (see Figure 6) as well as an increased risk of stent thrombosis (see Figure 7).

Figure 6: Crushing Technique – Kissing or not Kissing

Conclusions

Coronary bifurcation disease is frequent and can be adequately treated using an appropriate stenting strategy. The advent of DES has generated lengthy debates and a consensus has been reached as to a rational and safe approach applicable in more than 70% of cases. In cases where there is no lesion in the side branch or a purely ostial lesion, stenting the main branch with a jailed wire in the side branch followed by provisional T-stenting of the side branch after guide wire exchange appears to be the most rational and successful strategy, provided that final kissingballoon inflations are systematically performed.

Figure 7: Drug-eluting Stents in Bifurcation Lesions – Safety Data

In the presence of more complex lesions, namely when the side branch lesion extends beyond the ostium by more than 2 or 3mm, a second stent is required in the majority of cases. In such cases, the most appropriate technique between the Crush, simultaneous kissing stent or T-stenting techniques is still the subject of much debate. The data generated by the bench studies and preliminary clinical studies seem to favour the T-stenting technique starting with the main branch.

New dedicated DES and delivery systems will be available in the near future. These new devices will undoubtedly simplify the technical approach and possibly solve the problem of side branch restenosis.

  Previous     1    2    3   4    Next  

Keywords and Categories



Author(s) Biography
Dr Thierry Lefevre is Head of the Interventional Cardiology Department and Head of Research at the Institut Cardiovasculaire Paris Sud at Institut Hospitalier Jacques Cartier in Massy, France. He was previously a part-time hospital practitioner in the Cardiology Department at the Hopital de Pontoise, France, where he was in charge of the intensive care unit (ICU), echocardiography and interventional cardiology. He is a Fellow of the European Society of Cardiology (ESC) and a Fellow of the Society for Angiography and Interventions. Dr Lefevre earned his degree in medicine from the University of Paris V in 1985.
Dr Yves Louvard has worked in interventional cardiology at the Institut Cardiovasculaire Paris-Sud since 1992. Dr Louvard is a Fellow of both the French Society of Cardiology and the French College of Interventional Cardiology and is a member of the pedagogic board and Co-Director of the Inter-university Degree of Interventional Cardiology. Dr Louvard has made over 70 presentations, presented 60 posters, given almost 40 lectures, is author and co-author of 86 articles and 18 book chapters and has participated in various multicentre studies as an investigator. Dr Louvard gained an MD and a PhD from Paris VI University St Antoine in 1982.
Dr Marie-claude Morice has been head of the Insitiut Cardiovasculaire Paris Sud, since 1995. He is a guest speaker at all major international meeting of the European Society of Cardiology (ESC) the American Heart Association (AHA) and the American College of Cardiology (ACC). Dr Morice is an expert with the Regional Hospital Agency (ARH) and is Co-Director of the Paris course on revascularisation. He is a corresponding member of the Argentine Society of Cardiology and was elected Honorary Professor of the Universidad Del Salvador, Buenos Aires, Argentina in 2004. Dr Morice gained an MD in 1973 and a degree in cardiology in 1975.

Send Article Feedback
Title*:

Comment*:

Name*:
Email Address*:
Location*:

Add me to mailing list

I Agree to terms and conditions


Order Reprint


Order high-quality repints of any
articles on this website


Instructions for Authors
Instructions for authors, click here for details

Submit an Article
Submit an article, click here for details

  Copyright Touch Briefings 2005 - 2008    Promotional Opportunities | Terms & Conditions | Privacy Statement|

Articles : a b c d e f g h i j k l m n o p q r s t u v w x y z
Companies : a b c d e f g h i j k l m n o p q r s t u v w x y z
Events : a b c d e f g h i j k l m n o p q r s t u v w x y z
Keywords : a b c d e f g h i j k l m n o p q r s t u v w x y z

Specialities :

Arrhythmia Cardiac Imaging Congenital Heart Disease Coronary Artery Disease Heart Disease Prevention Heart Failure Hyperlipidemia Hypertension Interventional Cardiology Pediatric Cardiology Peripheral Artery Disease

Other Touch Group sites:   

Neurology - Endocrine Disease - Oncological Disease - Gastroenterology - Respiratory Disease